Pfizer Inc Stock Performance
| PFE Stock | USD 25.86 0.64 2.42% |
Pfizer has a performance score of 10 on a scale of 0 to 100. The company holds a Beta of 0.83, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pfizer's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pfizer is expected to be smaller as well. Pfizer Inc right now holds a risk of 1.41%. Please check Pfizer Inc total risk alpha, expected short fall, price action indicator, as well as the relationship between the value at risk and daily balance of power , to decide if Pfizer Inc will be following its historical price patterns.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
Actual Historical Performance (%)
One Day Return 2.34 | Five Day Return 2.26 | Year To Date Return 5.18 | Ten Year Return (8.45) | All Time Return 6.1 K |
Forward Dividend Yield 0.0665 | Payout Ratio | Last Split Factor 1054:1000 | Forward Dividend Rate 1.72 | Dividend Date 2026-03-06 |
| Pfizer dividend paid on 1st of December 2025 | 12/01/2025 |
1 | Pfizer Partners with Boltz to Use AI in Drug Discovery | 01/08/2026 |
2 | Evotec Is Up 17.3 percent After Landing 250m Sanofi Alliance And IR Overhaul Has The Bull Case Changed | 01/13/2026 |
3 | Pet Flavors Adds Randolph Legg to Board, Joining Fabian Kausche | 01/16/2026 |
4 | Pfizer Outperforms Broader Market What You Need to Know | 01/21/2026 |
5 | Texas AG Starts Investigation Into Vaccine-Related Financial Incentives | 01/22/2026 |
6 | The Top Stock to Buy With 30 for 2026 | 01/23/2026 |
7 | Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease | 01/26/2026 |
| Begin Period Cash Flow | 2.9 B | |
| Total Cashflows From Investing Activities | 2.7 B |
Pfizer Relative Risk vs. Return Landscape
If you would invest 2,348 in Pfizer Inc on October 30, 2025 and sell it today you would earn a total of 254.00 from holding Pfizer Inc or generate 10.82% return on investment over 90 days. Pfizer Inc is generating 0.1782% of daily returns assuming volatility of 1.4066% on return distribution over 90 days investment horizon. In other words, 12% of stocks are less volatile than Pfizer, and above 97% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Pfizer Target Price Odds to finish over Current Price
The tendency of Pfizer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 25.86 | 90 days | 25.86 | about 5.09 |
Based on a normal probability distribution, the odds of Pfizer to move above the current price in 90 days from now is about 5.09 (This Pfizer Inc probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Pfizer has a beta of 0.83 indicating as returns on the market go up, Pfizer average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pfizer Inc will be expected to be much smaller as well. Additionally Pfizer Inc has an alpha of 0.0984, implying that it can generate a 0.0984 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Pfizer Price Density |
| Price |
Predictive Modules for Pfizer
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pfizer Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pfizer Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pfizer is not an exception. The market had few large corrections towards the Pfizer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pfizer Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pfizer within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.1 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 0.66 | |
Ir | Information ratio | 0.06 |
Pfizer Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pfizer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pfizer Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pfizer Inc has a strong financial position based on the latest SEC filings | |
| About 68.0% of the company shares are owned by institutional investors | |
| On 1st of December 2025 Pfizer paid $ 0.43 per share dividend to its current shareholders | |
| Latest headline from medcitynews.com: Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease |
Pfizer Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pfizer Stock often depends not only on the future outlook of the current and potential Pfizer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pfizer's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.7 B | |
| Cash And Short Term Investments | 20.5 B |
Pfizer Fundamentals Growth
Pfizer Stock prices reflect investors' perceptions of the future prospects and financial health of Pfizer, and Pfizer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pfizer Stock performance.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0519 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 193.01 B | ||||
| Shares Outstanding | 5.69 B | ||||
| Price To Earning | 9.48 X | ||||
| Price To Book | 1.59 X | ||||
| Price To Sales | 2.34 X | ||||
| Revenue | 63.63 B | ||||
| Gross Profit | 46.97 B | ||||
| EBITDA | 18.13 B | ||||
| Net Income | 8.05 B | ||||
| Cash And Equivalents | 1.04 B | ||||
| Cash Per Share | 6.44 X | ||||
| Total Debt | 66.99 B | ||||
| Debt To Equity | 0.40 % | ||||
| Current Ratio | 1.59 X | ||||
| Book Value Per Share | 16.32 X | ||||
| Cash Flow From Operations | 12.74 B | ||||
| Earnings Per Share | 1.72 X | ||||
| Market Capitalization | 147.15 B | ||||
| Total Asset | 213.4 B | ||||
| Retained Earnings | 116.72 B | ||||
| Working Capital | 7.36 B | ||||
| Current Asset | 43.8 B | ||||
| Current Liabilities | 29.4 B | ||||
About Pfizer Performance
By analyzing Pfizer's fundamental ratios, stakeholders can gain valuable insights into Pfizer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pfizer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pfizer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 209.11 | 238.48 | |
| Return On Tangible Assets | 0.08 | 0.10 | |
| Return On Capital Employed | 0.11 | 0.22 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.10 | 0.10 |
Things to note about Pfizer Inc performance evaluation
Checking the ongoing alerts about Pfizer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pfizer Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pfizer Inc has a strong financial position based on the latest SEC filings | |
| About 68.0% of the company shares are owned by institutional investors | |
| On 1st of December 2025 Pfizer paid $ 0.43 per share dividend to its current shareholders | |
| Latest headline from medcitynews.com: Startup Fortitude Bio Launches to Beat Drug Resistance in Cancer, Expand ADCs to Autoimmune Disease |
- Analyzing Pfizer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pfizer's stock is overvalued or undervalued compared to its peers.
- Examining Pfizer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pfizer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pfizer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pfizer's stock. These opinions can provide insight into Pfizer's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |